Patrick Harriott

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease

Paula L. McClean, Victor A. Gault, Patrick Harriott et al. · European Journal of Pharmacology · 2009 · 185 citations

Synaptic Plasticity, Alzheimer's Disease, Diabetes +8

A strategy for designing inhibitors of α ‐synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

Omar M. A. El‐Agnaf, Katerina E. Paleologou, Brett Greer et al. · The FASEB Journal · 2004 · 184 citations

Alzheimer's Disease, Degenerative Pathology, Protein Misfolding +17

Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes

Victor A. Gault, Nigel Irwin, Brian D. Green et al. · Diabetes · 2005 · 167 citations

Proteinase-activated receptor-2: expression by human neutrophils

Gareth L. Howells, Marion G. Macey, Carla Chinni et al. · Journal of Cell Science · 1997 · 157 citations

Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin

Victor A. Gault, Finbarr O’Harte, Patrick Harriott et al. · Diabetologia · 2003 · 131 citations · Full text

Metabolic Syndrome, Insulin Signaling, Biochemistry +14